AmerisourceBergen Corporation (ABC): Price and Financial Metrics
AmerisourceBergen Corporation (ABC)
Today's Latest Price: $107.09 USD
Updated Jan 27 3:24pm
Add ABC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 77 in Medical - Services
See all "A" rated Strong Buy stocks
ABC Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for ABC is -186.37 -- better than only 0.18% of US stocks.
- With a price/sales ratio of 0.12, Amerisourcebergen Corp has a higher such ratio than only 2.01% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 17.81 for Amerisourcebergen Corp; that's greater than it is for 97.7% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Amerisourcebergen Corp are CCLP, GSS, CHWY, MKD, and WAT.
- Visit ABC's SEC page to see the company's official filings. To visit the company's web site, go to www.amerisourcebergen.com.
ABC Stock Price Chart Interactive Chart >
ABC Price/Volume Stats
| Current price | $107.09 | 52-week high | $112.48 |
| Prev. close | $108.84 | 52-week low | $72.06 |
| Day low | $106.61 | Volume | 566,654 |
| Day high | $109.76 | Avg. volume | 1,521,893 |
| 50-day MA | $102.27 | Dividend yield | 1.62% |
| 200-day MA | $98.37 | Market Cap | 21.87B |
AmerisourceBergen Corporation (ABC) Company Bio
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.
ABC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $107.09 | $35.82 | -67% |
Below please find a table outlining a discounted cash flow forecast for ABC, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amerisourcebergen Corp ranked in the 27th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for ABC, they are:
- The company's compound free cash flow growth rate over the past 5.54 years comes in at -0.07%; that's greater than merely 16.83% of US stocks we're applying DCF forecasting to.
- Amerisourcebergen Corp's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -37.46. This coverage rate is greater than that of only 3.38% of stocks we're observing for the purpose of forecasting via discounted cash flows.
- As a business, Amerisourcebergen Corp experienced a tax rate of about 27% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than 90.07% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -68% |
| 1% | -67% |
| 2% | -67% |
| 3% | -67% |
| 4% | -66% |
| 5% | -66% |
Want more companies with a valuation profile/forecast similar to that of Amerisourcebergen Corp? See DYNT, ABT, CDNA, CPIX, and HSIC.
Loading social stream, please wait...